The conventional MRI installation model depends on a fixed room. The patient is transported to the scanner. For the vast majority of diagnostic imaging needs, that model works well. But for a subset of critically ill patients, transport from the ICU or emergency department to the scanner suite is itself a clinical risk. Ventilator management during transport, the cardiovascular instability of moving a patient in septic shock, and the monitoring challenges of a magnetically restricted scanner room all create real hazards for patients who are too sick to move safely. Portable MRI addresses that hazard directly by bringing the scanner to the patient instead.
The first commercially viable bedside MRI system cleared by the FDA is the Hyperfine Swoop, a 64 millitesla device that can be wheeled to any standard clinical bay and operated without a shielded room. The system operates at ultralow field strength, which means it does not require the cryogenic infrastructure of a superconducting system and generates no significant fringe field. It runs on standard 110V power and can operate in the presence of standard clinical monitoring equipment.
We finance portable MRI systems for hospital health systems, academic medical centers, and healthcare networks adding point-of-care neuroimaging capability. The device cost range is lower than conventional MRI, and most transactions qualify for application-only financing. Our minimum transaction size is $50,000.
How Portable MRI Works and What It Can Do
The Hyperfine Swoop operates at 64 mT, roughly 24 times lower field strength than a 1.5T superconducting system. At that field strength, the Larmor frequency is approximately 2.74 MHz, far below the environmental RF interference spectrum that would require a shielded room. The system uses a dedicated chassis with integrated magnetic shielding that confines the small fringe field generated by the 64 mT magnet to within a safe distance around the device without requiring room construction.
The image quality at 64 mT is not comparable to 1.5T for general diagnostic applications. However, for the clinical use cases where portable MRI adds the most value, the image quality is adequate. Detection of hydrocephalus, ventricular hemorrhage, midline shift, large ischemic stroke, and white matter lesions in critically ill patients has been demonstrated with sufficient reliability to guide clinical decision-making. Serial imaging of ICU patients to monitor intracranial pressure dynamics or treatment response is a particularly strong use case, because the logistics of repeated conventional MRI for an unstable patient are prohibitive.
The Hyperfine platform connects to a tablet interface and uses AI-assisted image reconstruction to compensate partially for the lower SNR inherent in ultralow-field systems. The workflow is designed to be operated by clinical staff without specialized MRI technologist training, which is an important operational consideration for ICU deployment.
Clinical Settings for Portable MRI
Neurological ICUs and neurosurgical critical care units are the primary clinical environment for portable MRI adoption. The ability to perform serial brain imaging at the bedside, without the transport risk and logistical complexity of conventional MRI, has genuine value in monitoring TBI patients, post-surgical neurosurgical cases, and patients with elevated intracranial pressure.
Stroke programs at comprehensive stroke centers are another natural adopter. Rapid neuroimaging is a core requirement of acute stroke management, and portable MRI could extend imaging access to patients who are too unstable for conventional scanning during the acute phase of their presentation.
Rural and critical access hospitals that lack on-site MRI capability represent a different use case. A portable MRI provides a basic neuroimaging capability that allows at least the most critical diagnoses to be made on-site, which informs transport decisions and allows treatment to begin sooner. This is a meaningful access improvement for facilities that cannot justify the capital and operational cost of a full superconducting installation.
Academic and research institutions in Boston, Philadelphia, and Washington DC have been early adopters of portable MRI for both clinical and research applications, evaluating the technology's capability in controlled academic environments. We finance portable MRI for research purposes as well as clinical deployment.
Financing Terms for Portable MRI Systems
Portable MRI devices are priced significantly lower than conventional superconducting systems. The Hyperfine Swoop device cost puts most single-unit transactions below $200,000, which places them squarely in the application-only approval category. Multi-unit hospital fleet purchases can be structured as a single larger transaction with terms appropriate for the total contract value.
The financing structure for portable MRI can be a term loan that produces ownership at payoff or an operating lease that includes a service and subscription component aligned with how these devices are often sold. Hyperfine has offered subscription-based access models as well as outright purchase; we can structure financing to align with either commercial arrangement.
For hospitals or health systems with existing MRI financing relationships, a portable MRI acquisition can often be structured as an add-on transaction that leverages the existing lender relationship. Contact our team to discuss how to position a portable MRI acquisition within your institution's broader capital planning process.
Frequently Asked Questions
Below are the questions we hear from hospitals and health systems evaluating portable MRI financing.
Finance Portable MRI for Your Institution
Portable MRI is one of the more straightforward equipment finance transactions in the imaging space. The device cost is lower than conventional MRI, the documentation requirements are manageable, and approval can move quickly for qualified institutions. Contact our team to discuss your portable MRI financing needs.